San Francisco, CA, United States of America

Eric Stangeland


 

Average Co-Inventor Count = 4.0

ph-index = 2

Forward Citations = 6(Granted Patents)


Location History:

  • San Francisco, CA (US) (2020)
  • Boston, MA (US) (2023 - 2024)

Company Filing History:


Years Active: 2020-2024

where 'Filed Patents' based on already Granted Patents

5 patents (USPTO):

Title: Innovations by Eric Stangeland

Introduction

Eric Stangeland is a notable inventor based in San Francisco, CA. He has made significant contributions to the field of medicinal chemistry, particularly in the development of compounds that modulate GPR120 activity. With a total of five patents to his name, Stangeland's work is paving the way for new treatments for diseases mediated by GPR120.

Latest Patents

Stangeland's latest patents include innovative compounds that serve as GPR120 modulators. The first patent focuses on monocyclic compounds that are useful in modulating GPR120 activity. This patent outlines methods for treating diseases associated with GPR120 by administering these compounds and compositions. The second patent details bicyclic compounds that also function as GPR120 modulators, providing similar therapeutic applications.

Career Highlights

Throughout his career, Eric Stangeland has worked with prominent companies in the health sector. He has been associated with Valo Health, Inc. and Integral Health, Inc., where he has contributed to groundbreaking research and development in the field of health sciences.

Collaborations

Stangeland has collaborated with several professionals in his field, including Brian Raimundo and Elena S. Koltun. These collaborations have further enhanced his research and innovation efforts.

Conclusion

Eric Stangeland's contributions to the field of medicinal chemistry through his patents and collaborations highlight his role as a significant inventor. His work continues to influence the development of new therapeutic options for various diseases.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…